Pune, Maharashtra -- (SBWIRE) -- 02/16/2019 -- Fact.MR, in its latest report, estimates the global breast cancer diagnostics market to register a moderate expansion at 4.7% CAGR during the forecast period 2017 to 2022. Breast cancer is a cancer that develops when cells and tissues in the breast begin to grow out of control. Usually forming into a tumor, breast cancer is visible as a lump surrounding the internal breast tissues. Breast cancer tumor is malignant, and occurs almost entirely in women, apart from exceptional occurrences in men.

Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=55

By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

Competition Tracking

Key market players mentioned in Fact.MR's report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=55

Screening Practices of Breast Cancer Witnessed to Alter Early Detection Practices

Breast cancer has become the most common type of cancer for women across the globe. The number of women suffering from breast cancer is witnessing a surge. This has led towards necessity for efficient early detection of breast cancer. Mammography screening, an established method adopted across several countries, has been recently been observed to offer inconclusive test results. Risk-adapted, personalized therapy and screening are predicted to resolve these difficulties. In addition, tomosynthesis, a new imaging technology, has been seen to overcome the drawbacks of mammography.

Screening options for breast cancer have been witnessing a rise, and have been altering practices of early detection across industrialized economies. Moreover, countries such as Brazil, India and China are focusing on development of cost-effective screening strategies capable of being adapted as per requirements.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=55

Table of Content Covered in the report are:

Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary 19

Chapter 2 Global Breast Cancer Diagnostics Market Overview 21
2.1 Introduction 21
2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 21
2.1.2 Global Breast Cancer Diagnostics Market Definition 21
2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 22
2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 22
2.3 Global Breast Cancer Diagnostics Market Dynamics 22
2.3.1 Drivers 22
2.3.2 Restraints 22
2.3.3 Trends 23
2.4 Supply Chain 23
2.5 Epidemiology 23
2.6 List of Distributors 23
2.7 Average Pricing Analysis 23
2.8 Regulations 24
2.9 Key Participants Market Presence (Intensity Map) By Region 24

Access This Report @ https://www.factmr.com/checkout/55/S

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 25
3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 25
3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 25
3.1.1.1 Revenue (US$ Mn) Comparison, By Region 25
3.1.1.2 Market Share Comparison, By Region 26
3.1.1.3 Y-o-Y growth Comparison, By Region 27
3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 28
3.1.2.1 Revenue (US$ Mn) Comparison, By Region 28
3.1.2.2 Market Share Comparison, By Region 29
3.1.2.3 Y-o-Y growth Comparison, By Region 30
3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 31
3.1.3.1 Revenue (US$ Mn) Comparison, By Region 31
3.1.3.2 Market Share Comparison, By Region 32
3.1.3.3 Y-o-Y growth Comparison, By Region 33
3.1.4 KRAS Mutation Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 34
3.1.4.1 Revenue (US$ Mn) Comparison, By Region 34
3.1.4.2 Market Share Comparison, By Region 35
3.1.4.3 Y-o-Y growth Comparison, By Region 36
3.1.5 HER 2 Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 37
3.1.5.1 Revenue (US$ Mn) Comparison, By Region 37
3.1.5.2 Market Share Comparison, By Region 38
3.1.5.3 Y-o-Y growth Comparison, By Region 39
3.1.6 PSA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 40
3.1.6.1 Revenue (US$ Mn) Comparison, By Region 40
3.1.6.2 Market Share Comparison, By Region 41
3.1.6.3 Y-o-Y growth Comparison, By Region 42
3.1.7 CA Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 43
3.1.7.1 Revenue (US$ Mn) Comparison, By Region 43
3.1.7.2 Market Share Comparison, By Region 44
3.1.7.3 Y-o-Y growth Comparison, By Region 45
3.1.8 EGFR Mutation Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 46
3.1.8.1 Revenue (US$ Mn) Comparison, By Region 46
3.1.8.2 Market Share Comparison, By Region 47
3.1.8.3 Y-o-Y growth Comparison, By Region 48
3.1.9 Immunohistochemistry Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 49
3.1.9.1 Revenue (US$ Mn) Comparison, By Region 49
3.1.9.2 Market Share Comparison, By Region 50
3.1.9.3 Y-o-Y growth Comparison, By Region 51
3.1.10 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 52
3.1.10.1 Revenue (US$ Mn) Comparison, By Region 52
3.1.10.2 Market Share Comparison, By Region 53
3.1.10.3 Y-o-Y growth Comparison, By Region 54

Chapter 4 Global Breast Cancer Diagnostics Market Analysis and Forecast By End User 55
4.1 Global Breast Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 55
4.1.1 Hospital Associated Labs Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 55
4.1.1.1 Revenue (US$ Mn) Comparison, By Region 55
4.1.1.2 Market Share Comparison, By Region 57
4.1.1.3 Y-o-Y growth Comparison, By Region 57
4.1.2 Independent Diagnostic Laboratories Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 58
4.1.2.1 Revenue (US$ Mn) Comparison, By Region 58
4.1.2.2 Market Share Comparison, By Region 60
4.1.2.3 Y-o-Y growth Comparison, By Region 60
4.1.3 Cancer Research Institutes Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 61
4.1.3.1 Revenue (US$ Mn) Comparison, By Region 61
4.1.3.2 Market Share Comparison, By Region 63
4.1.3.3 Y-o-Y growth Comparison, By Region 63
4.1.4 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 64
4.1.4.1 Revenue (US$ Mn) Comparison, By Region 64
4.1.4.2 Market Share Comparison, By Region 66
4.1.4.3 Y-o-Y growth Comparison, By Region 66

And Continue....
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/ 
Read Industry News at - https://theswisstimes.com